National Bank of Canada’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,000
Closed -$43.8K 3188
2025
Q4
$43.8K Buy
32,000
+120
+0.4% +$251 ﹤0.01% 1990
2025
Q3
$87K Buy
31,880
+6,880
+28% +$24.4K ﹤0.01% 1794
2025
Q2
$87K Buy
25,000
+13,441
+116% +$53.1K ﹤0.01% 1820
2025
Q1
$42.4K Buy
11,559
+11,500
+19,492% +$42K ﹤0.01% 1918
2024
Q4
$95 Buy
+59
New +$61 ﹤0.01% 2802

Other funds holding STIM

National Bank of Canada's STIM Position: Q1 2026 in Review

National Bank of Canada sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 32,000 shares — an estimated $43.8K sold.

National Bank of Canada first reported a position in STIM in Q4 2024 and held it in 5 quarters. The position peaked at $87K in Q3 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • National Bank of Canada reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 32,000 Neuronetics shares in Q1 2026, an estimated $43.8K.
  • National Bank of Canada first reported a position in Neuronetics in Q4 2024 and held it in 5 quarters.
  • National Bank of Canada's Neuronetics position peaked at $87K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.